Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dr Reddy's
Dr Reddy's
Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials
Yahoo Finance
Wed, 08/21/24 - 11:28 am
Dr Reddy's
Kainomyx
Aurigene
antimalarial
malaria
Haleon reels in $633M with sale of ex-US nicotine replacement unit to Dr. Reddy's
Fierce Pharma
Wed, 06/26/24 - 11:30 am
Haleon
Dr Reddy's
consumer health
smoking cessation
India's Dr Reddy's expects healthy products pipeline in North America for FY25
Reuters
Wed, 05/8/24 - 11:05 pm
Dr Reddy's
earnings
India
Coya taps familiar friend Dr. Reddy’s to commercialize ALS med
Fierce Biotech
Wed, 12/6/23 - 08:58 pm
Coya Therapeutics
ALS
Dr Reddy's
COYA 302
Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
Endpoints
Mon, 02/27/23 - 10:04 am
generics
Dr Reddy's
Mayne Pharma
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
Biopharma Reporter
Thu, 01/5/23 - 10:11 am
Delpharm
CDMOs
drug development
The Netherlands
Dr Reddy's
Dr. Reddy's subsidiary hits the pause button on drug development for psoriasis
Endpoints
Fri, 12/16/22 - 10:32 am
Dr Reddy's
psoriasis
Aurigene
clinical trials
AUR101
Dr. Reddy’s launches extended-release rival to $200M Pfizer drug
Fierce Pharma
Mon, 07/11/22 - 05:52 pm
Dr Reddy's
Pfizer
overactive bladder
Toviaz
generics
After Big Pharma pulls back in Russia, Dr. Reddy's says business is booming
Fierce Pharma
Thu, 05/19/22 - 08:58 pm
Russia
Ukraine
India
Dr Reddy's
India's hesitance to condemn Russia puts the country's pharma industry in compromising position
Fierce Pharma
Wed, 03/9/22 - 12:00 pm
Russia
Ukraine
India
Cipla
Dr Reddy's
Torrent Pharmaceuticals
Sun Pharma
Dr Reddy’s jumps on medical cannabis train, buying Nimbus Health
Pharmaforum
Thu, 02/3/22 - 10:56 am
Dr Reddy's
Nimbus Health
Medical Marijuana
M&A
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Reuters
Tue, 01/4/22 - 10:46 pm
Dr Reddy's
Merck
generics
COVID-19
molnupiravir
Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar
Pharmaceutical Business Review
Thu, 12/9/21 - 10:57 am
Prestige BioPharma
Dr Reddy's
trastuzumab
biosimilars
Latin American
Asia
Dr. Reddy’s begins pilot of Russia’s Sputnik V vaccine in India
Pharmaceutical Business Review
Mon, 05/17/21 - 10:33 am
Dr Reddy's
vaccines
Sputnik V
Russia
COVID-19
clinical trials
Dr. Reddy’s to acquire select anti-allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
Pharmaceutical Business Review
Mon, 11/30/20 - 10:28 am
Dr Reddy's
Glenmark
M&A
anti-allergy
Bristol-Myers Squibb Cuts Deal, Delaying Threat to Top-Selling Revlimid
Motley Fool
Thu, 09/17/20 - 11:09 pm
Bristol-Myers Squibb
Dr Reddy's
Revlimid
Multiple Myeloma
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Fri, 12/6/19 - 09:54 am
Novartis
FDA
Gilenya
MS
multiple sclerosis
Mylan
Dr Reddy's
Torrent Pharmaceuticals
Aurobindo
generics
What has Zantac recall cost drugmakers? Dr. Reddy's gives a hint
Fierce Pharma
Mon, 11/11/19 - 07:54 pm
Zantac
OTC
product recalls
generics
Dr Reddy's
What's the definition of insanity? Dr. Reddy's knocked by the FDA for the fifth time this year
Fierce Pharma
Wed, 08/21/19 - 11:49 pm
Dr Reddy's
FDA
drug manufacturing
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Fierce Pharma
Thu, 08/15/19 - 10:39 am
FDA
Dr Reddy's
Copaxone
Teva Pharmaceutical
generics
Merck
Nuvaring
Pages
1
2
3
4
5
6
7
8
9
next ›
last »